New pill targets lung inflammation in sarcoidosis
Disease control
Recruiting now
This study is testing whether a new oral drug called OATD-01 can help control active lung sarcoidosis. About 96 adults with symptomatic lung sarcoidosis will take either the drug or a placebo pill for 12 weeks. Researchers will use special scans to see if the drug reduces lung in…
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC